Categories rss rss-es rss-pt Gadolinium-based Contrast Agents (GBCAs): Drug Safety Communication – Retained in Body; New Class WarningsMurilo Freitas - 13:00, 18 de diciembre de 2017471 0 Trace amounts of gadolinium may stay in the body long-term. https://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm589580.htm 0
